Materials Today Bio · 2024 · 13 citations · 32 references
MedicineCancer BiologyPharmacologyBiocompatibilityBiomaterialsTumor MicroenvironmentCancer NanomedicineCell-nanoparticle InteractionsNanocompositesNanomedicineNanoparticle DesignNanotoxicologyBiocompatible NanomaterialsCell-nanomaterial InteractionsFenton ReactionFenton-like ReactionsNanomaterial ToxicitySelf-assembled NanomaterialsTea PolyphenolsTumor Microenvironment Effects
Ferroptosis, a newly discovered form of regulated cell death, has garnered significant attention in the field of tumor therapy. However, the presence of overexpressed glutathione (GSH) and insufficient levels of H2O2 in the tumor microenvironment (TME) hinders the occurrence of ferroptosis. In response to these challenges, here we have constructed the self-assembled nanocomplexes (FeE NPs) utilizing epigallocatechin-3-gallate (EGCG) from green tea polyphenols and metal ions (Fe3+) as components. After grafting PEG, the nanocomplexes (FeE@PEG NPs) exhibit good biocompatibility and synergistically enhanced tumor-inhibitory properties. FeE@PEG NPs can be disassembled by H2O2 in the TME, leading to the rapid release of Fe3+ and EGCG. The released Fe3+ produces large amounts of toxic •OH by the Fenton reactions while having minimal impact on normal cells. The generated •OH effectively induces lipid peroxidation, which leads to ferroptosis in tumor cells. Meanwhile, the released EGCG can autoxidize to produce H2O2, which further promotes the production of •OH radicals and increases lipid peroxide levels. Moreover, EGCG also depletes the high levels of intracellular GSH, leading to an intracellular redox imbalance and triggering ferroptosis. This study provides new insights into advancing anticancer ferroptosis through rational material design, offering promising avenues for future research.
32
Kim Newton, Andreas Strasser, Nobuhiko Kayagaki et al. · Cell · 2024 · 869 citations · Full text
Engineering Magnetosomes for Ferroptosis/Immunomodulation Synergism in Cancer
Fan Zhang, Feng Li, Guihong Lu et al. · ACS Nano · 2019 · 360 citations
Medicine, Immunology, Oncology +17